Ferric Carboxymaltose Injection 50 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL
Reference Brands: Injectafer
Category: Anemia
Ferric Carboxymaltose Injection (Injectafer®/Ferinject®) is an intravenous iron therapy for treating iron deficiency anemia. With a concentration of 50 mg/mL, it allows for large, single-dose infusions. It is widely used in hospitals and clinics across the U.S. and EU.
Product Description:
Ferric Carboxymaltose Injection (brand names Injectafer® in the U.S. and Ferinject® in the EU) is a high-concentration intravenous iron therapy used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron or need rapid iron repletion. With a strength of 50 mg/mL, it allows for large, single-dose infusions, enhancing patient convenience and adherence. In the U.S. and EU, Ferric Carboxymaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In the pharmaceutical B2B sector, it is supplied by licensed manufacturers, contract partners, and distributors to meet institutional needs and ensure global availability.
Ferric Carboxymaltose Injection — third party manufacturing & bulk supply
Ferric Carboxymaltose Injection 50 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Ferric Carboxymaltose Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ferric Carboxymaltose Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ferric Carboxymaltose Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ferric Carboxymaltose is used to treat iron-deficiency anaemia in patients who cannot tolerate oral iron or need rapid replenishment of iron stores. It helps restore haemoglobin levels and improves symptoms related to low iron.
It is made from a stable iron–carbohydrate complex containing ferric hydroxide tightly bound to a carboxymaltose polymer. This structure allows controlled iron release and efficient absorption.
The main trade name is Injectafer in the US and Ferinject in many international markets.
It is manufactured by Vifor Pharma, and marketed in collaboration with other licensed partners in different countries.
The generic name is Ferric Carboxymaltose.
Brand names include Injectafer and Ferinject.
It is manufactured in multiple Vifor Pharma facilities and approved partner manufacturing sites across Europe and other regions.
Related Products
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
